AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Nightingale Health Oyj

Board/Management Information Dec 8, 2025

8507_rns_2025-12-08_1d010e38-793c-423e-9e71-4d96ee56881a.html

Board/Management Information

Open in Viewer

Opens in native device viewer

Change in Nightingale Health Plc's Management Team

Change in Nightingale Health Plc's Management Team

Nightingale Health Plc | Stock Exchange Release | December 08, 2025 at 10:35:00 EET

Tuukka Paavola, who has worked as Nightingale Health Plc’s Chief Financial Officer since December 2021, has left the company as of 8 December 2025.

Company begins the recruitment of a new Chief Financial Officer, and CEO Teemu Suna will act as interim CFO for the time being.

“I thank Tuukka for his service in the company and wish him success in his future endeavours,” says CEO Teemu Suna.

For further information, please contact

Teemu Suna, CEO

[email protected]

About Nightingale Health

At Nightingale Health, we believe there is a way to make healthcare better for everyone. We can reduce costs for payers and ease the burden on healthcare professionals while helping people live long and healthy lives. This is possible by introducing a healthcare logic built on prevention, where the aim is to reduce the number of sick people. That is why we have created the Nightingale Health Check. With every blood sample, we make better healthcare possible for everyone.

Nightingale Health operates globally with a parent company in Finland and subsidiaries in countries such as Japan, the United States, Singapore, and the United Kingdom. Nightingale Health has customers in more than 34 countries in the healthcare and medical research sectors. The Company's technology is being used in many of the world's leading health initiatives, such as the UK Biobank, and over 900 peer-reviewed publications validate the technology. The company's Series B shares are listed on the Main Market of Nasdaq Helsinki and on the OTCQX International market. Read more: https://nightingalehealth.com/

Image Attachments

Nightingale Health

Talk to a Data Expert

Have a question? We'll get back to you promptly.